Erin, Nuray <br/><br/>
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jan 2020 
 - 103-114 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-019-02444-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--genetics<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Aptamers, Nucleotide--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Doxorubicin--analogs & derivatives<br/>Drug Synergism<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout<br/>Orexin Receptors--genetics<br/>Polyethylene Glycols--pharmacology